Tristan R. Brown
Alternative energy, long/short equity, commodities, energy

BioAmber Remains A Risky Investment As It Pursues Commercialization

Executive summary

BioAmber Inc. is in the process of becoming a major player in the biobased succinic acid production market following its recent IPO. It is still at least six quarters away from achieving commercial-scale production, however, and the novelty of its pathway makes its commercialization prospects relatively uncertain. While management is optimistic that the company will achieve commercial-scale production by 2015, investors should be aware that the process is very uncertain and the risk of reductions to shareholder equity along the way is not low.

BioAmber Inc. (NYSE:BIOA) is a producer of biobased succinic acid. It is one of the newest additions to the ranks of publicly-traded companies that has opted to use biotechnology to produce biobased...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details